Clinical trial Recruiting at 7 sites Observational Ages 18 and up

Hybrid heart failure care with home monitoring

Official title: Evalutation of a Hybrid Care Pathway With Remote MONitoring for Heart Failure

Run by St. Antonius Hospital · NCT07680634 · Data updated 2026-11-12

This study tests whether a hybrid care pathway with remote monitoring helps adults with heart failure compared to usual care.

More Heart Failure trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment6000 (estimated)
SponsorSt. Antonius Hospital
Academic / other
Locations7 sites (Amsterdam, Utrecht and 6 other locations)
StatusRecruiting
StartedMay 1, 2023
Main results expectedDecember 30, 2030
Study endsJune 2031
Registry record updatedJuly 2, 2026
Trial IDNCT07680634 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a diagnosis of heart failure who can use digital tools and communicate in Dutch, treated at one of the seven participating hospitals.

Probably not a fit

Patients who are unwilling or unable to participate in home telemonitoring or who have end-stage or terminal conditions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a real-world, multicenter observational cohort study conducted in the Netherlands. It compares patients using home telemonitoring as part of a hybrid care pathway to patients receiving standard care without telemonitoring, across seven hospitals. The program collects daily home measurements and symptoms to trigger early interventions by a Medical Service Center, aiming to improve management in routine clinical practice. The study includes retrospective and prospective components to assess outcomes in typical care settings. Eligible participants are adults with heart failure who can use digital tools and speak Dutch, while those with end-stage disease or unwillingness to participate in remote monitoring are excluded.

Why it matters

Potential benefit: If successful, this approach could improve symptom control and reduce hospitalizations for heart failure patients.

How similar studies have gone: Previous real-world studies of telemonitoring in heart failure have shown mixed but promising signals for improved management and outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (at least 18 years or older)
* Diagnosed with heart failure according the prevailling ESC guideline
* Treatment at the outpatient clinic at one of the seven participating hospitals
* Sufficient digital literacy and adequate Dutch language proficiency by the patient or throught the informal caregiver.

Exclusion Criteria:

* Inability or unwillingness to participate in home telemonitoring
* Patients with end-stage heart failure or other terminal conditions

Where it's running

  • Olvg
    Amsterdam, Utrecht, Netherlands
    Recruiting
  • Catharina Hospital
    Eindhoven, Utrecht, Netherlands
    Recruiting
  • Medisch Spectrum Twente
    Enschede, Utrecht, Netherlands
    Recruiting
  • Martini Hospital
    Groningen, Utrecht, Netherlands
    Recruiting
  • St. Antonius Hospital
    Nieuwegein, Utrecht, Netherlands
    Recruiting
  • Canisius-Wilhelmina Hospital
    Nijmegen, Utrecht, Netherlands
    Recruiting
Show 1 more location
  • Maasstad Hospital
    Rotterdam, Utrecht, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.